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Background: Many recent studies using ChIP-seq approaches cross-referenced to trascriptome data and also to
potentially unbiased in vitro DNA binding selection experiments are detailing with increasing precision the p53-directed
gene regulatory network that, nevertheless, is still expanding. However, most experiments have been conducted
in established cell lines subjected to specific p53-inducing stimuli, both factors potentially biasing the results.
Results: We developed p53retriever, a pattern search algorithm that maps p53 response elements (REs) and ranks
them according to predicted transactivation potentials in five classes. Besides canonical, full site REs, we developed
specific pattern searches for non-canonical half sites and 3/4 sites and show that they can mediate p53-dependent
responsiveness of associated coding sequences. Using ENCODE data, we also mapped p53 REs in about 44,000 distant
enhancers and identified a 16-fold enrichment for high activity REs within those sites in the comparison with genomic
regions near transcriptional start sites (TSS). Predictions from our pattern search were cross-referenced to ChIP-seq,
ChIP-exo, expression, and various literature data sources. Based on the mapping of predicted functional REs near TSS,
we examined expression changes of thirteen genes as a function of different p53-inducing conditions, providing
further evidence for PDE2A, GAS6, E2F7, APOBEC3H, KCTD1, TRIM32, DICER, HRAS, KITLG and TGFA p53-dependent
regulation, while MAP2K3, DNAJA1 and potentially YAP1 were identified as new direct p53 target genes.
Conclusions: We provide a comprehensive annotation of canonical and non-canonical p53 REs in the human genome,
ranked on predicted transactivation potential. We also establish or corroborate direct p53 transcriptional control
of thirteen genes. The entire list of identified and functionally classified p53 REs near all UCSC-annotated genes
and within ENCODE mapped enhancer elements is provided. Our approach is distinct from, and complementary
to, existing methods designed to identify p53 response elements. p53retriever is available as an R package at:
http://tomateba.github.io/p53retriever.
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The p53 tumor suppressor is certainly one of the most
studied sequence-specific transcription factor to date.
Yet, much has still to be learned to fully describe its
transcriptional regulatory network, both in terms of the
crosstalk with other transcription factors and in terms of
the entire spectrum of regulated transcriptional target genes,
that can be both up-regulated or down-regulated [1–6].
Recently, several genome-scale techniques such as
ChIP-on-chip, ChIP-seq, and, more recently, ChIP-exo,
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creativecommons.org/publicdomain/zero/1.0/overlapping maps of p53 bound sites in the human gen-
ome in response to specific stimuli [7–17]. Correlation
between occupancy data and modulation of transcrip-
tion levels of nearby genes helped identifying additional
direct p53 target genes, of which >200 have been estab-
lished [2, 15]. Furthermore, new methodologies are re-
fining the potential to map the p53 network taking also
into account the kinetics of transcriptional initiation
[18, 19]. It is worth noting that, to date, most experi-
ments have been developed in cancer-derived cell lines
that may represent an adapted environment potentially
biasing a comprehensive annotation of physiological
p53 target sites [7, 20]. To this respect, the impact of
specific p53-inducing stimuli and the differentiation/rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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investigated [4, 7, 8, 21, 22].
Considerable attention has been given to the sequence
and structural features of p53 binding sites that provide
for p53 recruitment to target sites [2, 5, 6]. It is now
more clear that the loose definition of p53 response
element (RE) [23] that has been used for many years
comprises a wide range of DNA binding affinity, occu-
pancy rates and transactivation potentials measured by
various types of assays, and that specific differences in
the definition of p53 REs are evident between purely
in vitro biochemical assays and in vivo occupancy mea-
surements [24–28].
The canonical p53 consensus found in many identified
binding sites of mostly up-regulated p53 target genes
consists of two copies of the palindromic half-site
RRRCWWGYYY separated by a spacer of 0–13 bp, in
which R = purine, W =A or T and Y = pyrimidine. The-
oretically, each p53 monomer binds five nucleotides –
i.e., one monomer binds the I° quarter site R1R2R3C1
W1 and the second monomer the II° quarter site
W2G1Y1Y2Y3-. As reviewed previously, the rather degen-
erate p53 consensus sequence, reflects the established
observation that in virtually all cases of validated p53
REs, an optimal consensus site is not found, because of
mismatches, in some cases resulting in partial binding
sites, referred to as non-canonical REs [5, 24, 29]. This
has raised the hypothesis of a selection pressure to limit
the intrinsic potential of p53 proteins to target binding
sites, thereby allowing for modulation of p53-induced
transcriptional changes by signal transduction pathways
affecting p53 protein amount, DNA binding potential,
quaternary structures and/or availability of multiple
trans-factors [30–36]. For example, p53 REs with lower
DNA binding affinity appear to be more frequent in tar-
get genes involved in apoptosis [28]. Consistent with this
hypothesis, optimized p53 REs have been recently stud-
ied in experimental models and in vitro for their kinetic
and thermodynamic interactions with p53 as well as
transactivation potential and shown to provide for high
level of p53-mediated transactivation even at low p53
protein levels [25].
Functional assays in a defined experimental setting
provided by the yeast S. cerevisiae have been extensively
used to characterize the transactivation potential of p53
RE in isogenic conditions and exploit variable expression
of p53 under an inducible promoter to yield a matrix of
transactivation results, to some extent comparable in
precision to that of a biochemical assay in a test tube [5,
24, 26, 28, 37–41]. Further, high correlation was re-
ported between results in yeast and transactivation or
occupancy data in cancer cell lines [24, 27]. For example,
experiments in this model system led to identify functionally
active half-site and 3/4 site (3Q) p53 REs, a group of REscollectively considered as non-canonical that were then
mapped and validated also in human cells [7].
Here we have combined all the data obtained so far
with the yeast-based p53 transactivation assay and devel-
oped an algorithm, p53retriever, to scan DNA sequences,
identify p53 REs and classify them based on predicted
transactivation potential into five broad categories. As
unique features, this algorithm takes into account co-
operative interactions between groups of mismatches in
two p53 dimers and scores also non-canonical REs.
Specifically we used this approach to map functional
p53 REs in the proximity of all annotated coding genes,
searched for high affinity p53 REs in the entire genome,
and mapped functional p53 REs within ENCODE-
defined distant enhancer regions. The predictive power
of mapping p53 REs with high functional score near
transcription start sites (TSS) was validated for a panel
of 13 genes, using cell lines differing for p53 status, two
p53-inducing stimuli and measuring relative expression
by qPCR at three time points. APOBEC3H, E2F7, GAS6,
TRIM32, PDE2A, KCTD1, DICER, MAP2K3, DNAJA1,
HRAS, KITLG, TGFA and potentially YAP1 were con-
firmed or identified as p53 target genes.
Results and discussion
Development and implementation of p53retriever, a
pattern search code that identifies canonical and
non-canonical p53 REs based on predictions from
transactivation assays
In general, the degree of p53 binding depends on various
factors including the state of the p53 protein, its cofac-
tors, and the sequence composition of the p53-RE [5,
32]. Because easier to predict than the p53 state, compu-
tational algorithms were developed to explore p53 bind-
ing through sequence motif analysis. The majority of
these algorithms, such as p53MH [42], do not directly
consider the response element (RE) potential to drive
p53-dependent transactivation. On the contrary, p53re-
triever is based on a set of manually curated rules, de-
rived from a compendium of p53 transactivation data
obtained using a yeast-based assay [24, 26, 37, 43, 44].
REs are scored from five (= highly functional REs ac-
tivity) to one (= unlikely functional REs) (Fig. 1a). The
grade represents the inferred transactivation potential
rather than being an indication of the percent similarity
to the canonical p53 consensus sequence. For full site
p53 REs the grade considers a severe negative impact of
a spacer between the two half sites larger than two nu-
cleotides (Fig. 1c). Variable p53-RE spacer lengths are
known to affect transactivation capacity. Only two previ-
ous studies tried to incorporate the spacer length as one
of the relevant features [11, 45], calculating a penalty
score directly proportional to spacer length. Also in our
algorithm, based on previous results, we attribute high
Fig. 1 Summary of RE sequence features and associated grades in p53retriever. a Grade: classification of REs reflecting associated functional scores.
The color code matching the 5 different grades will be maintained in all figures. b Mismatch label: classification of mismatches in different positions.
High penalties are given to mismatches located in the core consensus sequence (label A and B), lower penalties are given when mismatches are
gradually distant from the core (label C and D). Label O is given to a site without mismatches. Mismatches group penalties: different penalties are
attributed to groups of mismatches according to how they are scattered or grouped along the site. c Schematic representation of the main rules on
which p53retriever search algorithm is based. The full list of rules is listed in Additional file 1. The p53 consensus sequence is presented, grouping
dinucleotide motifs that were revealed to provide a specific impact on transactivation potentials, based on our previous studies (see text for details)
[28]. Penalties are indicated by an increment in the number of the “-” symbol and a color code broadly matching the grade scale. Single mismatches
are more penalized when affecting a base in the internal portion of the RE, as indicated. On the contrary, the AT motif at the center of the CWWG
core is a positive feature, particularly in the case of non-canonical REs (3Q = 3Q sites and half sites)
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(Fig. 1c). Indeed, REs with a long spacer length are also
confirmed to be rarely bound by p53 in vivo [7, 14, 46, 47].
Many of the computational approaches for identifying
putative p53-REs define how similar that putative bind-
ing site is to the consensus, but do not consider the local
context of single mismatches within the RE. In our
approach mismatches from consensus are also weighted
depending on their position within the RE 20-mer
sequence, given the finding that mismatches in the
quarter sites at the interface between the two half sites
have a more severe impact likely due to cooperative
interactions among two p53 dimers [28] (Fig. 1b). In
addition, interaction effects between groups of mis-
matches are also considered. In general, any combination
of mismatches is penalized in a different way according
to their location, considering that p53 is functionallyactive as a tetramer, that each p53 monomer interacts
with a 5 nt motif (quarter site) and that the p53 tetramer
is thought to be assembled as a dimer of dimers [48]. If
groups of mismatches are localized in the same “quarter”
of the RE, the score is less penalized than if the same
mismatches were scattered in different quarters (Fig. 1b).
Importantly, non-canonical REs consisting of 3Q sites
and ½ sites [5, 7] are considered functional p53 REs
with specific pattern searches. A graphical view of these
features presented as “penalty matrix” summarizes
the main features of our pattern search (Fig. 1c). The
complete list of the rules used to attribute the functional
score is presented (Additional file 1). The p53retriever
pattern search algorithm, together with functions to better
visualize search results, has been implemented as an R
package and is available for download at: http://tomateba.
github.io/p53retriever.
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human promoters
We applied p53retriever to the set of sequences in the
human genome placed around annotated transcriptional
start sites (TSS), selecting a window from -10 kb to 10 kb.
The entire list of identified REs, chromosomal coordinates,
official gene name, distance from TSS and RE sequence
features resulting in the given grade, is available in
Additional file 2.
The distribution of identified p53 REs grouped based on
the functional score, shows a very large preponderance of
“grade 1” REs, that are considered as unlikely functional
(Fig. 2a). Also, the distribution of RE scores is highly
skewed, with only 0.05 % of REs obtaining the highest
grade, supporting the hypothesis of a selecting pressure to
reduce p53 binding affinity and provide plasticity in the
modulation of p53-mediated stress responses in vivo
[4, 28]. Very recent analyses confirmed that p53 REs that
are more highly conserved in evolution are relatively weak
p53 RE sites displaying lower levels of occupancy com-
pared to higher affinity REs that exhibit low evolutionary
conservation [47]. Grade five sequences either lack
entirely mismatches, or contain two or fewer mismatchesGrade
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Fig. 2 Analysis of p53 REs found in human promoters. a Pie chart displayin
promoters. b Comparison between the frequencies of REs found in human
sequences after applying local permutations (to preserve the local GC cont
frequency is the same, > 1 if the frequency is higher in real promoters, <1
significant, the binomial test p-value is 4.84E-04 for grade 5 (**), <1E-15 for
position of REs in all human promoters, centered on the TSS position. The gre
from the grade. Colored lines represent the density distribution of REs wi
displayed in the legend). The specific positions of grade 5 REs are dotted
on the position of REs in the human promoters of 228 p53 target genes,
specific positions of grade 4 and 5 REs are dotted under the histogram (iin the external positions (R1,Y6/R4,Y3, see Fig. 1c), and
contain the positive AT motif in the CWWG core. The
vast majority of REs that can be considered functional are
in the grade two category. Predicted to be poorly respon-
sive on their own, these REs could participate in the regu-
lation of gene expression conditional to other features,
such as the local sequence context of promoter architec-
ture. Included in the grade two category are ~30 % of all
half sites mapped (Fig. 2a). A unique feature of our search
tool is the specific pattern search for non-canonical 3Q
sites. Interestingly, even though mismatches in the two
internal quarter sites have an higher impact on p53 trans-
activation for 3Q sites compared to full sites, and thus
result in a final lower grade, many 3Q sites obtained a
grade higher than 2. Hence, a great number (13,744) of
p53 REs are predicted to be functional even though the
entire motif is not present. This observation strongly
supports recent reports suggesting that p53 REs match
the consensus in one half site, with the two central quarter
sites being somehow less variable [14]. It is also consistent
with the recent report of the frequent identification of
p53 half-sites among p53 ChIP-seq peaks lacking full
sites [47].All human promoters















































>= 1 >= 2 >= 3 >= 4 =5Grade
g the distribution of grades associated to REs found in all human
promoters, and the frequencies of REs found in scrambled promoter
ent). The comparison is shown for each grade. The ratio is 1 if the
if the frequency is higher in scrambled promoters. All enrichments are
all the other grades (***). c p53 occupancy metaprofile, based on the
y histogram displays the probability distribution of all REs independently
th higher grades (the grade threshold corresponding to each color is
in yellow under the histogram. d p53 occupancy metaprofile, based
published in [15]. The color scheme is the same as in panel C. The
n yellow for grade 5, red for grade 4)
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human promoters with what we would expect by chance,
by applying p53retriever to sets of scrambled sequences
obtained by local permutations of real promoter se-
quences (see Methods and Additional file 3: Table S1).
Local permutations allowed us to preserve the local GC
content of promoter regions, showing in fact an increase
in GC content around the TSS (see Additional file 3:
Figure S1). From this analysis we could determine that the
frequency of REs in the global set of human promoters is
slightly but significantly higher than the frequency of REs
in scrambled sequences (Fig. 2b). This soft enrichment is
plausible, given that we are considering all known human
TSS and not specific populations of genes. Grade five and
three are the most enriched class of REs when comparing
the frequency of each grade (Fig. 2b).
Mapping all the REs considering their position with re-
spect to the TSS, we obtained an occupancy metaprofile of
p53 REs, displayed in Fig. 2c. This occupancy profile reveals
a general decrease of REs in the region proximal to TSS
(from -2 kb to +2 kb). This decrease affects all REs, inde-
pendently from the grade, and appears to be a consequence
of the local increase in GC content, since we observed the
same effect in scrambled sequences when applying local
permutations (Additional file 3: Figure S2). Overall the REs
reduction (approximately of ¼.) could be interpreted as a
selection against a high density of active p53 REs from pro-
moter regions of non-target genes that is limited to about 2
kbs from TSS. This reduction is driven by the general in-
crease in GC content around the TSS, which more globally
is instrumental in the interplay between chromatin con-
formation and transcription processes. On the other hand,
when restricting our analysis to the promoter region of
known p53 targets, we found an entirely different land-
scape. Fig. 2d displays the promoter occupancy metaprofile
of REs identified by p53retriever in a group of 189 HGNC
genes listed as targets of p53 in literature and collected in
[15, 45]. Interestingly, this profile shows the highest prob-
ability density in the region closer to the TSS, especially for
functional REs with grade four and five (red line in Fig. 2d).
Indeed, recent data reported a prevalence of p53 REs
nearby the TSS of known target genes [16, 47].
Comparison with other p53 binding site datasets and
search tools
To further verify if p53retriever recognized already
established p53 binding sites, we compared our approach
with lists of p53 target genes and REs previously reported.
The detailed results of all comparisons are contained in
Additional file 4.
First, we used our method to score 81 REs sequences
that are consistently bound by p53 according to seven
different ChIP-seq datasets, reported in [15]. All these
sequences were picked by p53retriever as potentiallyfunctional. Interestingly, excluding one sequence, all p53
REs from this list obtained a grade greater than one with
the majority being of grade 5, confirming that our tool can
discriminate functional and well-known REs (Fig. 3a).
Next, we applied p53retriever on p53 REs obtained by
Chip-exo analysis [14], providing near-nucleotide resolution
of p53 bound sites in response to a variety of genotoxic
stresses. (Fig. 3b). While 28 % of sites were not classified,
the majority of bound sequences from ChIP-exo obtained a
grade greater than 1, with a predominance of grade four
and five, (Fig. 3b, left panel). Interestingly, we saw a clear
correlation between higher relative occupancy and higher
RE grade (Fig. 3b, right panel). Looking in more detail to
the “no grade” group, we noticed that all non-scored
sequences differed from the canonical RE site for features
which are highly penalized by our algorithm, like a number
of mismatches higher than three scattered on three
different quarter sites. Nevertheless, we could show that
these not-scored sequences are mostly characterized by low
occupancy values (white boxplot in Fig. 3b right panel,
Wilcoxon rank sum test p-value=1.29E-09). Consistently,
when considering the subset of regions increasingly bound
by p53 after all the stimuli used in [14], the percentage of
“no grade” drops to 17.6 % (Additional file 3: Figure S3).
We also extended the comparison to a Chip-seq dataset,
reported in [17] (Fig. 3c) and obtained an overall similar
distribution of RE grades. The percentage of regions with
“no grade” is 22.8 %.
Next, we extended the comparisons to other lists of
REs, starting from two small collections of reported p53
REs, based on heterogeneous experimental approaches
[2, 15, 45]. Only a minority of those REs obtained the
highest grade, and the proportion of sequences not
scored as potentially functional was approximately 40 %
(Additional file 3: Figure S4). It has to be said that the
REs reported in those lists are not guaranteed to be the
ones actually or solely responsible for the responsiveness
of the associated genes to p53.
Even though total mRNA levels are an indirect measure-
ment of p53 transcriptional activity, they reflect the
transcriptome status upon p53 activation. Thus, we did an
additional comparison using microarray data obtained
after p53 activation upon Doxorubicin treatment of MCF7
cells [49]. The majority of differentially expressed, up-
regulated genes turned out to have a p53 binding sites
with grade three (Fig. 3d), and exhibited a specific enrich-
ment of REs with grade >3 near the TSS (Additional file 3:
Figure S5). Similar comparisons were done with lists of
p53 target genes in curated databases such as TRANSFAC
and IPA. Again, the majority of these genes have a RE of
grade three predicted by p53retriever in their promoter
region (Fig. 3d). Using Ingenuity Pathway analysis (IPA),
grade five and grade four human promoters revealed a
strong p53 pathway signature (Additional file 5).
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Fig. 3 Comparison of p53retriever with other p53 binding site datasets and tools. a Pie chart displaying p53retriever classification on a list of 81
regions commonly identified by 7 different ChIP-seq experiments [15]. b Left panel: pie chart displaying p53retriever classification on a list of
2250 regions identified by ChIP-exo [14]. Right panel: boxplot displaying for each grade assigned by p53retriever to ChIP-exo sequences, the
distribution of the corresponding ChIP-exo occupancies, measured in [14]. n.g. = no grade given by p53retriever. c Pie chart displaying p53retriever
classification on a list of 4416 regions identified by ChIP-seq in [17]. d p53 target gene lists from curated databases (Biobase and IPA) or from
expression datasets (Doxo up: genes up-regulated upon doxorubicin treatment) were compared to the list of p53 promoter REs obtained with
p53retriever. Presented in the bar graph are the predicted p53 REs grouped by the maximum functional grade identified by p53retriever in
their promoter. e Comparison between p53 REs identified in human promoters by p53retriever, and the corresponding score given by Jaspar
p53 PWM (MA0106.2), based on ChIPseq data. REs are divided in 5 groups along the horizontal axis, corresponding to the grade assigned by
p53retriever. For each group, the distribution of the scores given by Jaspar PWM is represented as a violin plot, i.e., a box plot with a rotated
kernel density plot on each side. Jaspar scores range from 0 (the RE is not identified) to 1 (the RE is optimal)
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standard PWM approach, using two PWMs provided by
the JASPAR database (see Methods). All REs identified
by p53retriever in the set of human promoters were
scored in parallel with both JASPAR PWMs: the com-
parison with the JASPAR PWM derived from ChIPseq
data is shown in Fig. 3e. Although there is a high agree-
ment on REs with the maximum grade, very close to the
optimal p53 consensus, the comparison shows diver-
gences between the two methods for the lower grades.
For example, a considerable population of REs assigned
to grade four by p53retriever receives very low scores
from JASPAR. This is likely due to the presence of ¾
sites that are over-penalized by the PWM approach. On
the other hand, many REs with low grades are highly
scored by JASPAR, that doesn’t penalize groups of scat-
tered mismatches. Apart from grade 1, we can observe a
linear trend between the two scoring systems if we look
at the median values of the boxplots displayed in Fig. 3e,
so we can conclude that the two approaches are distinct
and complementary. On the other hand, the second
JASPAR matrix, based on SELEX data, gives misleading
results, since even optimal REs (grade 5) receive low
scores (Additional file 3: Figure S6).High grade p53 REs are enriched in distant enhancers
Recent functional genomics approaches, particularly
resulting from the ENCODE initiative, have revealed
that transcription is rather pervasive, that enhancer se-
quence can be very distant, at least in terms of primary
sequence, from genes, and that active enhancers can be
mapped based on specific histone code marks [50, 51].
Hence, we exploited this rich body of available informa-
tion to map p53 REs in distal enhancer sites, using
DNAse hypersensitive sites tracks. We filtered out sites
overlapping with promoter regions defined in the previ-
ous sections, and considered a population of 43,787 dis-
tal regions, whose length distribution is displayed in
Fig. 4a. p53retriever was run on this set of regions, and
the complete results are provided in Additional file 6.
The grade distribution of REs found in distal DNAse re-
gions is displayed in Fig. 4b. The frequency of REs in
these regions is significantly higher than the frequency
found in human promoters and also in random se-
quences (Fig. 4c and Additional file 3: Figure S7). The
overall fold enrichment is 3.54, but this trend grows pro-
portionally to the grade of the REs, reaching a peak with
grade 5. In fact, 144 high grade REs are found within
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Fig. 4 Analysis of p53 REs found in distal DNAse hypersensitive
regions. a Boxplot of the nucleotide length of human distal DNAse
hypersensitive regions, determined as described in Methods. b Pie
chart displaying the distribution of grades associated to REs found in
human distal DNAse hypersensitive regions. c Comparison between
the frequencies of REs found in human distal DNAse hypersensitive
regions, and the frequencies of REs found in random sequences
with the same GC content. The comparison is shown for each
grade. The ratio is 1 if the frequency is the same (horizontal dotted
line), > 1 if the frequency is higher in DNAse regions, <1 if the
frequency is higher in random sequences. All enrichments of REs
mapped to distal DNAse hypersensitive regions are highly significant
(Binomial test p-value < 1E-20). d Pie charts displaying p53retriever
classification on two lists of regions identified by ChIP-seq in [17] as
proto-enhancers (upper panel) and enhancers (lower panel)
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grade five REs is 16.3 (Fig. 4c). Presently, it is undeter-
mined if this enrichment for high quality binding sites
reflects a common trend for sequence-specific transcrip-
tion factors or a distinct feature of p53 family proteins.
Consistent with our results, higher levels of p53 occu-
pancy in distal enhancers compared to promoters was
very recently reported based on ChIP-seq analysis of
lymphoblastoid cell lines treated with doxorubicin [47].
Additionally, Chip-seq analysis reported in [17] allowed
us to expand the study of p53 REs in enhancers regions.
In fact that paper provided p53 bound regions classified
as enhancers based on ENCODE annotation or as proto-enhancers, where p53 could act as pioneer transcription
factor. Interestingly, this latter group showed an enrich-
ment for high scoring (grade four and grade five) p53 REs
according to p53retriever and a lower proportion of se-
quences with no grade (Fig. 4d, top panel).
New direct p53 target genes identified based on the p53
RE functional search tool
High-activity, or non-canonical p53 REs predicted to be
moderately active were mapped by our tools near the
TSS of genes that are not completely established or
novel putative direct p53 target genes. To infer the pre-
dictive power of the pattern search on p53-dependent
transcriptional changes, 13 genes were selected and their
expression was tested followed by qPCR in cell lines dif-
fering for p53 status (MCF7, two derivative clone so
called MCF7 vector and MCF7shp53, HCT p53+/+ and
HCT p53−/−) and at different time points (8, 16, 24 h)
after p53 activation by two different treatments, i.e.,
Doxorubicin -a genotoxic chemotherapeutic drug- and
Nutlin-3A -an MDM2 inhibitor- (Fig. 5a) (Additional file
7). Results support p53-dependent up-regulation for
most genes. The p53-dependency is confirmed by the
absence of induction in HCT p53−/− and MCF7shp53
cell lines, despite the different p53 status between the
two cells lines (a p53-null and a partial knockdown cell
line, respectively). In some cases, the increase in gene
expression compared to the mock condition was time-
dependent. Differences in these kinetic features were
apparent between the two treatments applied. E2F7 was
inducible by Doxorubicin at different time points, while
after Nutlin-3A treatment an early up-regulation was
followed by repression, which appeared to be p53-
dependent. GAS6 and KCTD1 had a similar trend espe-
cially in MCF7 cells. Differences were noted between
MCF7 and the MCF7-vector derivative clone in the
magnitude or the kinetics of relative expression changes
(e.g., PDE2A, APOBEC3H, KCTD1, DNAJA1, DICER).
Nine of the thirteen candidates (PDE2A, GAS6, E2F7,
APOBEC3H, KCTD1, TRIM32, TGFA, KITLG, HRAS)
were selected among the list of genes having both a
predicted binding sites in our algorithm output with a
grade higher or equal to 2, and a reported p53 binding
sites on ChIPseq datasets [7, 8]. For all of them except
TRIM32, total mRNA levels are also reported as upregu-
lated after Doxorubicin treatment by microarray data [49].
Although the induction is not directly proportional to the
grade, we confirmed p53 dependent induction by qPCR
for all of them in time/cell line dependent manner. Even
though TRIM32 is not upregulated after Doxorubicin
treatment in all the tested cell lines, it is upregulated upon
Nutlin-3A treatment, confirming ChIP-seq data. Besides
their p53 binding sites, these candidates were selected













































Fig 5 p53-responsiveness of target genes associated with predicted functional REs. a qPCR results of 13 selected genes. Fold of changes values
(ΔΔCq) upon each treatment are presented as a heatmap. Upper part shows mRNAs level after Nutlin-3A treatment while the lower shows the
same after Doxorubicin (Doxo) treatment. Expression levels were tested in different cell lines (MCF7, HCT +/+, HCT −/−, MCF7 vector and MCF7 shp53)
and at different time points (8, 16 and 24 h) (Details are presented in Additional file 7). For each gene, the “Grade” column presents the binding site
grade reported by our algorithm. “ChIPseq” column shows the presence (+) or absence (−) of reported p53 binding sites [8]. “Doxo” column presents
mRNA levels obtained by microarray data [49]. b Positional representation of p53 binding sites in TSS proximity for DICER, YAP1, DNAJA1, MAP2K3. Bar
height is proportional to the binding site grade. Grade 5 is yellow, grade 4 is red, grade 3 is green, grade 2 is blue and grade 1 is grey. c p53 occupancy
on the promoter of DICER, YAP1, DNAJA1 and MAP2K3 comparing Mock and Doxo condition in MCF7 cells. P21, well-known p53 direct target, is a
positive control. ACTB is used as a reference. Sites validated by ChIP are indicated by a * symbol in Figure 5b
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HRAS, KITLG and TGFA), in transcription (KCTD1), and
DNA editing (APOBEC3H) (see Supplementary Text in
Additional file 3).
For the remaining four genes, whose REs are displayed
in Fig. 5b, we performed a chromatin-immunoprecipitation
experiment in MCF7 cells treated with Doxorubicin for16 h. Weak p53 occupancy was observed by qPCR at
DNAJA1 and MAP2K3 loci after doxorubicin treatment,
while a region containing a predicted grade 3 category p53
RE in the YAP1 gene showed evidence for p53 occupancy
in the mock condition. Our results did not support direct
p53 binding to the DICER promoter, consistent with a
previous study [52] (Fig. 5c).
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YAP1 as new direct p53 target genes, although the level of
transactivation was relatively low.
DNAJA1 can act as a co-chaperone of Hsc70 that was
previously associated to radioresistance phenotype in wild
type p53 glioblastoma cells treated with farnesyltransferase
inhibitors [53]. Recently, overexpression of DNAJA1 was
associated with a reduction of pancreatic cancer cell
survival and with c-Jun repression [54].
MAP2K3 participates in the MAP kinase cascade and
can phosphorylate p38. This protein was identified as a
senescence-promoting factor in human breast epithelial
cells [55]. However, it has also been associated to tumor
invasion potential and to be regulated at transcriptional
level by NFY, NF-κB and gain-of-function mutant p53 [56].
The Yes-associated protein 1 (YAP1) is a transcriptional
regulator involved in the Hippo signaling pathway.
Evidences support both an oncogenic and a tumor sup-
pressor role for YAP1, linked to ABL1-induced apoptosis
[57]. YAP1 protein was found capable to bind the p53
promoter and a positive feedback loop was proposed
based on the finding that p53 can bind the YAP promoter
[58]. In part consistent with this view we found p53-
dependent YAP1 gene up-regulation both after doxorubicin
and Nutlin-3A treatment.
Conclusions
Several previous tools were developed to identify bona fide
p53 response elements, starting with pioneering in vitro se-
lection experiments that led to the initial and still accepted
definition of the consensus p53 RE [11, 42, 45, 59, 60]. The
majority of these tools were based on position weight
matrices derived from results of in vitro approaches,
namely competitive gel shift assays and SELEX, more
recently integrated with results obtained from Chromatin
immunoprecipitation experiments. A systematic effort to
quantify changes in DNA binding affinity (dissociation
constants) using fluorescence anisotropy titration led to
the development of a p53 binding site predictor algorithm
[60]. This tool was also used to search genome wide for
high affinity p53 REs and to map naturally occurring
single nucleotide polymorphisms (SNPs) that can impact
on the DNA binding affinity of p53. The functional
relevance of SNPs within p53 REs has been established in
several reports [15, 24, 27, 44, 61].
All position weight matrix approaches assume additive
contributions of the individual positions within the RE
sequence, and except for [45] and [11], all tools do not
specifically weigh the impact of spacers between half site
decameric RE motifs in the 0-13 nt range. This spacer
length was in fact considered neutral in the initial in vitro
experiments [23]. However, DNA binding assays where RE
sequence are embedded in longer DNA molecules, com-
petitive binding experiments in microfluidics, ChromatinImmunoprecipitation assays, yeast- and mammalian-cell
based transactivation assays all indicate that even a single
nucleotide spacer between p53 RE half sites can reduce
transactivation potential [5, 24, 27, 44]. In fact, when the
spacer is longer than 2–3 nt the two decameric half sites no
longer show cooperative interactions [24, 28, 62], although
when the distance in primary sequence approach one
helical pass, transactivation potential appears to increase
beyond additivity [24], yet remaining much lower compared
to the absence of a spacer. The negative impact of spacer is
even more dramatic for TAp73 [62] and TAp63 proteins,
but not for ΔNp63 [63], suggesting that the structure as
well as the sequence of DNA binding sites can lead to con-
formational changes in the quaternary tetrameric structure
of p53 family proteins, and that intrinsic differences exist in
the oligomerization state of these proteins [64].
We have coded in p53retriever sequence and structural
features of p53 REs impacting on transactivation potential
that were revealed in the past several years using our
yeast-based transactivation assay [5, 26, 28, 63, 65, 66].
The resulting algorithm has several distinctive features
compared to previous tools, particularly for scoring inter-
actions among groups of mismatches, non-canonical 3Q
sites and half sites p53 REs, weighing the impact of
consensus mismatches considering their position within
the full site RE sequence, i.e., giving higher penalty to
mismatches in the two internal quarter sites, and weighs
consensus sequence variations within dinucleotide motifs
in the core and flanking regions [28] (Fig. 1, Additional file
1). Possible interactions between nearby half site p53 REs
or clusters of full site and 3Q sites are currently not
considered by our algorithm.
We mapped and ranked functional REs near TSS for all
annotated transcripts in UCSC (Additional file 2). Further,
we exploited ENCODE data and provide a cartography
of ranked p53 REs within distant DNAse hypersensitive
sites, considered as distant enhancers (Additional file
6). In these regions we found a significant 16-fold
enrichment of high grade REs with respect to the basal
frequency expected by chance or observed in promoter
regions. An enrichment for high grade REs was also
found among proto-enhancer sequences bound by p53
identified by ChIP-seq [17]. It is worth noting that our re-
sults represent a projection from all DNAse hypersensitive
sites, irrespective of the specific tissues in which they are
active. Tissue variability may influence which REs are
selectively bound. An additional layer of complexity is
represented by the known interplay between different
transcription factors. This important aspect is not
included in our analysis that is focused on p53 alone.
Although the data on which the algorithm is construed
are the outcome of transactivation assays measured from
chromatinized promoter-reporter construct, the isogenic
nature of the yeast-based functional assays, minimizes
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p53; at the same time distinct chromatin features of the
natural context of the REs’ location in vivo may certainly
influence the associated gene transcriptional responsive-
ness to p53. Hence the yeast-based results might be more
similar to ChIP-seq and ChIP-exo results, albeit with a
more quantitative power.
Undoubtedly different ChIP-seq experiments do not
agree with each other and there is limited overlap among
the results obtained with different cell lines or using differ-
ent treatments to activate p53. While global differences in
occupancy could be related to differences in accessibility
between different tissue-derived cells or to distinct p53
post-translational modifications or cofactors activated by
different treatments, it was interesting to find that the list
of p53 bound sites that are common to multiple ChIP-
experiments were highly enriched for high scoring (grade
four and grade five) REs and none of them failed to be
classified by our tool (Fig. 3a). Instead, when examining
individual ChIP-seq or even, although to a lower extent,
ChIP-exo data, 20 % to 30 % of p53 bound fragments did
not contain a motif scored by p53retriever. While those
sites may represent examples of p53 proteins tethered to
DNA by protein interactions, the manual inspection of
“no grade” sites from the ChIP-exo datasets showed that
the majority of these sites resemble p53 response elements
but contain several (three or more) “core” mismatches
scattered on three different quarter sites. These multiple
mismatched REs are not presently scored by p53retriever,
but would probably result in weak responsiveness.
Consistently, the majority of no grade ChIP-exo REs
showed lower occupancies (Fig. 3b right panel).
Finally, we decided to validate a few of the predictions
from the pattern search, particularly for non-canonical 3Q
sites using cell lines as a model. 13 genes with mapped
functional REs were chosen. Overall, despite our algo-
rithm doesn’t consider the system complexity of transcrip-
tional regulation in living cells and the response variability
upon each different p53 stimulus, results support p53-
dependent transactivation for the majority of them. Based
on the combined qPCR and ChIP results we conclude that
DNAJA1, MAP2K3, and potentially YAP1 can be consid-
ered new direct p53 target genes, linking p53 to yet
additional potential biological outcomes. Furthermore,
our data further establish the very recent findings of
PDE2A, GAS6, E2F7, APOBEC3H, KCTD1, TRIM32,
HRAS, KITLG and TGFA as p53 target genes.
Methods
Implementation of pattern search rules in p53retriever
We implemented the set of manually curated rules
(Additional file 1) in an R package called p53retriever.
p53retriever source and binary files are available
on Github, at (http://tomateba.github.io/p53retriever/).p53retriever contains a main function that identifies poten-
tial REs. This function needs as input an arbitrary DNA
sequence, and returns a table containing information about
the identified REs, such as position, sequence, spacer
length, mismatch label and grade. The format of the output
is similar to Additional file 6. Many functions are also
provided in order to graphically display the results. The
package is documented with usage examples, and fully
integrated with other CRAN and Bioconductor packages.
In particular, p53retriever depends only on the previous
installation of the Bioconductor Biostrings package.
Human promoters dataset
Human promoter sequences were extracted from the
UCSC database (http://genome.ucsc.edu/) considering, for
each transcript with a distinct TSS, the 20 kB region
surrounding the transcription binding site (genome build
GRCh37/hg19). The final dataset consists of 23,541 pro-
moter sequences, associated to distinct UCSC identifiers
and corresponding to 18,355 HGNC genes.
Human distal DNase regions dataset
Encode DNase-seq regulatory regions (genome build
GRCh37/hg19) were obtained from the following cell
lines: Gm12878, H1hesc, Helas3, Hepg2, Hmec, Hsmm,
Hsmmt, Huvec, K562, Monocd14, Nha, Nhdfad, Nhek,
Nhlf, Osteobl, Hsmmfshd, Lncap, Nb4, Nt2d1,Panc1. The
consensus was defined as the merge of all the regions that
were present in at least two cell lines. Only distal regions,
with more than 10 kb from the nearest annotated TSS,
were kept in the dataset, in order to avoid overlap with
promoter regions. The final dataset consists of 43,787
regions, with a mean length of 673.3 bases.
Simulations with random sequences
Sets of scrambled promoter sequences were generated by
local permutations (bin size = 500 nt) of human promoter
sequences (−10 kb, +10 kb from TSS). This allowed to
preserve the local GC content in the random model; p53
REs were then identified and classified with p53retriever.
The random simulation was run ten times, and the results
were compared to REs identified in real human promoters.
Set of random sequences were generated, with the same
number and the same GC content (44 %) of human DNA
sequences; p53 REs were then identified and classified
with p53retriever. The random simulation was run ten
times, and the results were compared to REs identified in
human distal DNase regions promoters.
Pathway analysis of DEGs
All pathways analyses were performed using IPA (www.
ingenuity.com). Only direct interactions were considered
in the setting parameters.
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Several lists of p53 targets, identified by their HGNC
symbol, were extracted from online databases such
as Biobase TRANSFAC (http://www.biobase-international.
com/product/transcription-factor-binding-sites) and IPA,
or from previous publications, referenced in the main text.
These lists were used to select populations of genes among
our dataset of human promoters, and analyze the grade of
the REs identified by p53retriever (as shown in Fig. 2d).
Several sets of p53 RE sequences or p53 bound regions
were taken from previous publications, referenced in
the main text. p53retriever was run directly on these
sequences (as shown in Fig. 3a, b, c).
Comparison with JASPAR PWMs
Two PWMs for p53 were downloaded from the JASPAR
database (http://jaspar.genereg.net/). One PWM, MA0106.1,
is built on SELEX data, while the second, MA0106.2, is
built on ChIPseq data. The original values of the down-
loaded PWMs were based on nucleotide frequencies and
therefore more similar to Positional Frequency Matrices.
These frequency values were transformed in log2 prob-
ability ratio values with the PWM function implemented
in the Bioconductor Biostring package, using a multi-
nomial model with a Dirichlet conjugate prior to calculate
the estimated probability of base b at position i. The final
score of a match ranges from 0 to 1. All REs identified by
p53retriever in the set of human promoters were scored
with JASPAR PWMs: the comparison with MA0106.2 is
shown in Fig. 3d, while the comparison with MA0106.1 is
shown in Additional file 3: Figure S2.
Cell lines and culture conditions
The human breast adenocarcinoma-derived MCF7 cell
line (p53 wild type) was obtained from the InterLab Cell
Line Collection bank, ICLC (Genoa, Italy) while the colon
adenocarcinoma HCT116 (p53+/+) cell line and its p53−/−
derivative were a gift from B. Vogelstein (The Johns
Hopkins Kimmel Cancer Center, Baltimore, Maryland,
USA). MCF7 cells stably expressing an shRNA targeting
p53 (MCF7shp53) or control cells (MCF7vector) were
kindly provided by Dr. Agami (Netherlands Cancer
Institute, Amsterdam). Cells were normally maintained in
DMEM or RPMI (BioWhittaker, Lonza, Milan, Italy) sup-
plemented with 10 % FCS, antibiotics (100 units/ml penicil-
lin plus 100 mg/ml streptomycin) and 2 mM glutamine.
Puromycin (Sigma-Aldrich, Milan, Italy) was used to main-
tain the selection, at 0.5 μg/mL as final concentration.
RNA extraction
Cells were seeded into 6-well plates and allowed to reach
70-80 % of confluence before treating with 1.5 μM Doxo-
rubicin or 10 Μm Nutlin-3A. Doxorubicin was purchased
from Sigma-Aldrich (Milan, Italy) while Nutlin-3A wasobtained from Alexis Biochemicals (Enzo Life Science,
Exeter, UK). After 8 h, 16 h or 24 h of treatment cells were
harvested and total RNA was extracted using RNeasy Mini
Kit (Qiagen, Milan, Italy) according to the manufacturer’s
instructions. In-column DNAse treatment (RNase-Free
DNase Set, Qiagen, Hilden, Germany) was performed to
remove DNA contamination during the extraction. Purity
of RNAs (A260/A280 value of 1.8–2.1) and concentration
were measured using the Nanodrop spectrophotometer.qPCR
cDNA was generated starting from 1 μg of RNA by using
the RevertAidTM First Strand cDNA Synthesis Kit
(Fermentas, Milan, Italy) in 20 μL as final volume follow-
ing manufacturer’s instructions. Primers were designed by
Primer-BLAST performing in silico analysis as well as
standard curves to define assay specificity and efficiency
(Additional file 7). All qPCR assays were performed on
CFX Touch Real-Time PCR Detection System (Bio-rad,
Milan, Italy) in a 384-well plate format. Optimal primer
concentrations (200nM-400nM) were determined by iden-
tifying conditions resulting in the lowest Cq combined
with absence of primer dimer formation. Reaction
volumes were set at 10 μl. SYBR Green assays contained
5X KAPA SYBR FAST qPCR Mastermix (Kapa Biosystems,
Resnova, Rome, Italy), 400 nM each primer (MWG,
Operon, Ebersberg, Germany) and 25 ng of cDNA. Initial
thermal cycling conditions were 1 cycle of 95 °C for 3
mins, followed by 40 cycles of 95 °C for 30 s, 60 °C for
20 s, 72 °C for 60 s. At the end a melt curve analysis was
performed. Post-run relative mRNA quantification was
obtained using the comparative Cq method (ΔΔCq), where
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
β-2microglobulin (B2M) served as reference genes.ChIP assays
MCF7 cells were cultured in complete medium in a 150-
mm Petri dishs and when reaching 70/80 % confluence
were treated for 16 h with Doxo. The procedure for cross-
linking, sonication, IP and analysis followed a previously
described protocol [49]. Antibodies used for ChIP assays
were: p53 (DO-1) and IgG (sc-2025 or sc-2027) (Santa
Cruz Biotechnology®) (Millipore). ChIP analysis was
performed with the comparative Cq method (ΔΔCq) and
normalized as % of input, using β-actin gene as negative
control and p21 as positive control for p53 enrichment.Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files. p53-
retriever source and binary files are available on Github,
at (http://tomateba.github.io/p53retriever/).
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Additional file 1: Complete list of the rules used to attribute the
functional score in the pattern search algorithm.
Additional file 2: Complete list of identified REs within human
propoter regions (−10 kb, 10 kb from TSS). The list contains
chromosomal coordinates, official gene name, distance from TSS and RE
sequence features resulting in the given functional grade.
Additional file 3: Figures S1–S7, Table S1 and Supplementary
Information.
Additional file 4: Comparison between p53retriever classification
and lists of published p53 bound regions.
Additional file 5: Gene lists from data curated Ingenuity Pathway
(TP53 Canonical Pathway) were compared to prediction and
functional ranking of p53 REs. The RE grade is stated in the name of
the various worksheets. A) Grade four and grade five. B) All grade 3, 4,
and 5.
Additional file 6: Complete list of identified REs within ENCODE
distal DNAse regions. The list contains chromosomal coordinates and
RE sequence features resulting in the assigned functional grade.
Additional file 7: qPCR data summarized in Figure 5. For each gene,
time point and treatment time, the average fold change of three
biological repeats is presented along with the Standard Deviation.
The results obtained with different cell lines are presented in different
worksheets
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